Literature DB >> 25672754

Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells.

Nicole Marquardt1, Vivien Béziat1, Sanna Nyström1, Julia Hengst2, Martin A Ivarsson1, Eliisa Kekäläinen1, Helene Johansson3, Jenny Mjösberg1, Magnus Westgren4, Tim O Lankisch2, Heiner Wedemeyer2, Ewa C Ellis3, Hans-Gustaf Ljunggren1, Jakob Michaëlsson1, Niklas K Björkström5.   

Abstract

Although NK cells are considered innate, recent studies in mice revealed the existence of a unique lineage of hepatic CD49a(+)DX5(-) NK cells with adaptive-like features. Development of this NK cell lineage is, in contrast to conventional NK cells, dependent on T-bet but not Eomes. In this study, we describe the identification of a T-bet(+)Eomes(-)CD49a(+) NK cell subset readily detectable in the human liver, but not in afferent or efferent hepatic venous or peripheral blood. Human intrahepatic CD49a(+) NK cells express killer cell Ig-like receptor and NKG2C, indicative of having undergone clonal-like expansion, are CD56(bright), and express low levels of CD16, CD57, and perforin. After stimulation, CD49a(+) NK cells express high levels of inflammatory cytokines but degranulate poorly. CD49a(+) NK cells retain their phenotype after expansion in long-term in vitro cultures. These results demonstrate the presence of a likely human counterpart of mouse intrahepatic NK cells with adaptive-like features.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25672754     DOI: 10.4049/jimmunol.1402756

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  113 in total

1.  CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.

Authors:  Bérengère Salomé; Alejandra Gomez-Cadena; Romain Loyon; Madeleine Suffiotti; Valentina Salvestrini; Tania Wyss; Giulia Vanoni; Dan Fu Ruan; Marianna Rossi; Alessandra Tozzo; Paolo Tentorio; Elena Bruni; Carsten Riether; Eva-Maria Jacobsen; Peter Jandus; Curdin Conrad; Manfred Hoenig; Ansgar Schulz; Katarzyna Michaud; Matteo Giovanni Della Porta; Silvia Salvatore; Ping-Chih Ho; David Gfeller; Adrian Ochsenbein; Domenico Mavilio; Antonio Curti; Emanuela Marcenaro; Alexander Steinle; Amir Horowitz; Pedro Romero; Sara Trabanelli; Camilla Jandus
Journal:  Blood Adv       Date:  2019-11-26

2.  Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.

Authors:  Sebastian Lunemann; Gloria Martrus; Angelique Hölzemer; Anais Chapel; Maja Ziegler; Christian Körner; Wilfredo Garcia Beltran; Mary Carrington; Heiner Wedemeyer; Marcus Altfeld
Journal:  J Hepatol       Date:  2016-04-04       Impact factor: 25.083

Review 3.  Transcriptional regulation of innate lymphoid cell fate.

Authors:  Nicolas Serafini; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

Review 4.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

Review 5.  Emerging insights into natural killer cells in human peripheral tissues.

Authors:  Niklas K Björkström; Hans-Gustaf Ljunggren; Jakob Michaëlsson
Journal:  Nat Rev Immunol       Date:  2016-04-28       Impact factor: 53.106

Review 6.  NK cells and type 1 innate lymphoid cells: partners in host defense.

Authors:  Hergen Spits; Jochem H Bernink; Lewis Lanier
Journal:  Nat Immunol       Date:  2016-06-21       Impact factor: 25.606

7.  Liver-resident NK cells and their potential functions.

Authors:  Hui Peng; Rui Sun
Journal:  Cell Mol Immunol       Date:  2017-09-18       Impact factor: 11.530

8.  Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival.

Authors:  Matteo Donadon; Kelly Hudspeth; Matteo Cimino; Luca Di Tommaso; Max Preti; Paolo Tentorio; Massimo Roncalli; Domenico Mavilio; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2017-05-23       Impact factor: 3.452

Review 9.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 10.  The Broad Spectrum of Human Natural Killer Cell Diversity.

Authors:  Aharon G Freud; Bethany L Mundy-Bosse; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-11-21       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.